PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
News|Articles|June 26, 2014
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-07-02-2014
- Volume 10
- Issue 7
Recipharm and CTC Enter Collaboration
Author(s)Pharmaceutical Technology Editors
Recipharm and CTC will offer packages for Phase I studies.
Advertisement
Source:
Articles in this issue
about 12 years ago
GSK Offers $1 Million Award for Healthcare Innovationsabout 12 years ago
Covance MarketPlace Connects Biotech with Potential Partnersabout 12 years ago
Pharma Capacity to Produce Cytotoxic Injectable Drugs Constrictsabout 12 years ago
Changing Market Dynamics Require New Approaches to Innovationabout 12 years ago
Cost Is No Longer the Driving Force for Outsourcingabout 12 years ago
Cytovance Biologics Manufactures AM0010 for ARMO BioSciencesabout 12 years ago
Globalization Challenges Drug Regulatorsabout 12 years ago
Aesica Pharmaceuticals S.r.I. Implements Serialization Systemabout 12 years ago
Frontage Labs Plans Expansion of CMC Facilityabout 12 years ago
Novartis Hosts 13th Annual Malaria Expert PanelAdvertisement
Related to this article
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Lori Dingledine, QC Director Microbiological Control and GTIC Operations at Genentech, provided input on the regulations surrounding raw material manufacturing and use for ATMPs in a presentation at the 2026 PDA/FDA Joint Regulatory Conference.
FDA opens applications for its Expedited IND Pilot, pairing sponsors with qualified research institutions to test rolling CMC review ahead of first-in-human trials.
2026 approvals, clinical data, and licensing deals are advancing subcutaneous biologics, reducing patient burden, and reshaping biopharma drug strategy.
Karthik Iyer, Eli Lilly, details an AI system linking GMP findings, audits, and deviations for cited, inspection-ready regulatory intelligence.
Advertisement
Advertisement